BofA raised the firm’s price target on Boston Scientific (BSX) to $100 from $90 and keeps a Buy rating on the shares. The firm, which ...

Johnson & Johnson, Abbott and Intuitive Surgical made a mixed start to earnings season last week. The second wave of the medtech industry’s latest earnings season arrives this week, with Boston ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Boston Scientific (BSX – Research Report) yesterday and set a price target ...

In this photo illustration, a Boston Scientific Corporation logo seen ... [+] displayed on a smartphone and pc screen in the ...

BOSTON — Tramping from North Station ... in Public Policy and Public Finance at the Harvard Kennedy School. “Connecting North and South stations will eliminate a transportation bottleneck ...

Boston Scientific Corporation BSX is gaining traction in the international regions. New regulatory approvals and accretive acquisitions bode well for long-term growth. The stock carries a Zacks ...

In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against the other best healthcare stocks to buy according to hedge funds. Investing in ...

The Farapulse pulsed field ablation system. [Image courtesy of Boston Scientific] Boston Scientific (NYSE: BSX) + continues to expand the reach of its Farapulse pulsed field ablation system for ...

The club’s current yellow and blue City Connect uniforms, which are inspired by the Boston Marathon, will remain. “Given the popularity of our yellow uniforms with our players and fans ...

The latest trading session saw Boston Scientific (BSX) ending at $84, denoting a +0.1% adjustment from its last day's close. The stock trailed the S&P 500, which registered a daily gain of 0.28%.